… In this review, we summarize the potential therapeutic candidates under development for
COVID-19 based on clinical trials and describe their potential mechanisms of action (Fig. 2 and …

… The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
… Coronavirus disease-19 (COVID-19) is an illness caused by this novel coronavirus and can …

… million have died due to COVID-19 disease progression. COVID-19 presents flu-like symptoms
… Although social distancing reduces transmissibility, COVID-19 vaccines and therapeutics …

… and summarizes the potential treatment candidates, which can provide guidance in … The
major proposed therapeutic candidates that seem promising for the treatment of COVID-19 are …

… Although there is no approved drug or vaccine for COVID-19, … select appropriate laboratory
and clinical candidate drugs (4). … to review therapeutic candidates for the emerging COVID-19 …

… overview of COVID-19, along with an introduction to the biology of the SARS-CoV-2 virus.
Then, we will describe in detail the vaccine candidates and various therapeutic strategies, …

… With COVID‐19 vaccine availability likely 12–18 months away, there is an immediate need
to examine COVID‐19 therapeutic candidate options, which could arrive on the scene more …

… COVID-19, and were validated by Ennaid Therapeutics, LLC in a propreitary study. The
compounds exclusive to the patent are not included in the list of the 51 validated actives and are …

… We selected a total of 72 most current or ongoing clinical trials of the COVID-19 drug candidates
… to discover and develop antiviral drug candidates for COVID-19 (Table 1 and Figure 2). …

… order to develop a suitable therapeutic candidate against COVID-19. The repurposed drugs
… on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. …